[ET Net News Agency, 1 June 2023] CARDIOFLOW-B (02160) fell 0.59% to HK$1.68.
It hits an intra-day low of HK$1.67, hitting a historical low, and an intra-day high of
HK$1.81. The total shares traded was 7.21 million, with a value of HK$12.68m. The active
buy/sell ratio is 36:64, with net selling turnover of HK$3.58m. CHINA INV INFO accounts
for greatest net responsive buying turnover of HK$1.96m, with volume weighted average
price of HK$1.762. CHINA INNOVATION MARKET SER accounts for greatest net responsive
selling turnover of HK$471,810, with volume weighted average price of HK$1.782. The stock
has fallen a combined 20.38% over the past 7 consecutive trading days.
Basic Information
=================
--------------------------------
Nominal 1.680 % Chg -0.59%
High 1.810 Low 1.670
Shares Tr 7.21m Turnover 12.68m
10-D SMA 1.946 %H.V 55.347
20-D SMA 2.092 VWAP 1.758
50-D SMA 2.283 RSI14 18.790
--------------------------------
Status: Hitting a historical low, active buy/sell ratio is 36:64, with net selling
turnover of HK$3.58m, falling a combined 20.38% over the past 7 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
CARDIOFLOW-B (02160) 1.68 -0.59
GENSCRIPT BIO (01548) 17.70 +2.19
INNOVENT BIO (01801) 36.80 +0.27
JXR (01951) 4.08 +0.74
EVEREST MED-B (01952) 11.00 +1.10
WUXI BIO (02269) 42.25 +5.49
WUXI APPTEC (02359) 67.20 +4.19
BEIGENE (06160) 134.40 +0.90
ZAI LAB (09688) 26.40 +2.13
AKESO (09926) 35.45 +1.58
---------------------------------------------
(ed)